The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
作者:Fouzia Machrouhi、Nouara Ouhamou、Keith Laderoute、Joy Calaoagan、Marina Bukhtiyarova、Paula J. Ehrlich、Anthony E. Klon
DOI:10.1016/j.bmcl.2010.09.088
日期:2010.11
analogues of compound C, a non-specific inhibitor of 5′-AMP-activated proteinkinase (AMPK), using a computational fragment-based drug design (FBDD) approach. Synthesizing only twenty-seven analogues yielded a compound that was equipotent to compound C in the inhibition of the human AMPK (hAMPK) α2 subunit in the heterotrimeric complex in vitro, exhibited significantly improved selectivity against a subset
我们使用基于计算片段的药物设计 (FBDD) 方法设计并合成了化合物 C 的类似物,这是一种 5'-AMP 活化蛋白激酶 (AMPK) 的非特异性抑制剂。仅合成 27 种类似物就产生了一种化合物,该化合物在体外抑制异源三聚体复合物中的人 AMPK (hAMPK) α2 亚基方面与化合物 C 等效,对相关激酶子集的选择性显着提高,并显示出增强的细胞抑制AMPK。
SELF-ASSEMBLING ULTRASHORT PEPTIDES MODIFIED WITH BIOACTIVE AGENTS BY CLICK CHEMISTRY
申请人:AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
公开号:US20150352220A1
公开(公告)日:2015-12-10
The present invention relates to hydrogels comprising a first peptide with a covalently linked bioactive agent and optionally a second peptide. The present invention further relates to uses of the hydrogel for delivery of the bioactive agent or as an implant. The present invention further relates to drug delivery devices, implant, pharmaceutical or cosmetic compositions comprising the hydrogel. The present invention further relates to methods of local treatment of diseases and to methods for preparing the first peptide and the hydrogels.
The tetrahydrothienopyridine derivatives were derived from aminomethylcyclohexylcarboxylic acid as a lead moiety. Evaluation of the antiplatelet activity and receptor binding assay revealed that compound 1 (ME3277) was a novel and potent non-peptide and non-amidinophenyl GPIIb/IIIa antagonist. Copyright (C) 1996 Elsevier Science Ltd
?-Azidoacetophenone und ihre katalytische Reduktion
作者:H. Bretschneider、H. H�rmann
DOI:10.1007/bf00899309
日期:——
NOVEL COMPOUND WITH PLATELET AGGREGATION INHIBITOR ACTIVITY